Get started
Work

Supplementary Table 1 from Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303

Year: 2023
Type: supplementary-materials
Abstract: PDF file - 81K, Primary antibodies Used for Immunohistochemistry.
DOI: 10.1158/1078-0432.22455218
Authors: Amanda Psyrri, Ju-Whei Lee, Eirini Pectasides, Maria Vassilakopoulou, Efstratios K. Kosmidis, Barbara A. Burtness, David L. Rimm, Harold J. Wanebo, Arlene A. Forastiere
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361884065
Cites:
Cited by:
Related to: 10